Congress Year-End Legislative Package Delivers for the Rare Community
These measures follow the successful passage of H.R. 6833 in October, which included a five-year reauthorization of critical FDA user-fee programs that help ensure rare disease patients gain timely access to essential therapies and diagnostic tools.
Source: pressreleasepoint.com